Many abnormalities of the P53 network have been implicated in the pathogenesis of AML (64) and, moreover, the activity of nucleoporins (in particular Nup98) and both topoisomerases can be modulated by P53 (65–67). The gene discussed is NUP98; the disease is acute myeloid leukemia.